
Cyprumed and MSD Enter Licensing Agreement for Oral Peptide Therapeutics
MSD receives a non-exclusive license for Cyprumed's drug delivery technology for developing oral peptide therapeutics.
MSD receives a non-exclusive license for Cyprumed's drug delivery technology for developing oral peptide therapeutics.
US CDMO Adare Pharma Solutions is to add a high-shear mixer granulator at its Pessano, Italy facility, to complement existing fluid bed capabilities. The new mixer can provide wet granulation using either aqueous or organic-based solutions.
Portuguese CDMO Hovione has expanded its continuous manufacturing capabilities with the start-up of a new facility at Loures. The company said it can now offer customers a commercial continuous tableting platform to support their key needs.